Showing results (2351-2360 of 2,512) with videos related to
Sort By:
Pageof 252
Urologic Oncology|June 9, 2018
Commentary on "Prognostic effect of carcinoma in situ in muscle-invasive urothelial carcinoma patients receiving neoadjuvant chemotherapy."D E Thomas, H Z Kaimakliotis, K R Rice, et al.Nucleic Acids Research|July 12, 2018
Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesisYing-Ying Lee, Myth Ts Mok, Wei Kang, et al.Nature Microbiology|November 1, 2016
Indexing the Pseudomonas specialized metabolome enabled the discovery of poaeamide B and the bananamidesDon D Nguyen, Alexey V Melnik, Nobuhiro Koyama, et al.Cell Death & Disease|September 7, 2013
Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic strokeD Yang-Wei Fann, S Y Lee, S Manzanero, et al.Anticancer Research|November 20, 2001
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesionsA L Cheng, C H Hsu, J K Lin, et al.Journal of Neurotrauma|July 9, 2020
In-Hospital Mortality for the Elderly with Acute Traumatic Spinal Cord InjuryTom Inglis, Dan Banaszek, Carly S Rivers, et al.Briefings in Bioinformatics|March 30, 2021
Multi-omic analysis suggests tumor suppressor genes evolved specific promoter features to optimize cancer resistanceDan Huang, Xiansong Wang, Yingzhi Liu, et al.Medchemcomm|August 16, 2018
Identification of imidazo[1,2-b]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signallingR Moslin, D Gardner, J Santella, et al.BMJ Open|December 25, 2025
Building a library of acute traumatic spinal cord injury images across Canada: a retrospective cohort study protocolNaama Rotem-Kohavi, Suzanne Humphreys, Vanessa K Noonan, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 6, 2024
A blood-based multi-pathway biomarker assay for early detection and staging of Alzheimer's disease across ethnic groupsYuanbing Jiang, Hyebin Uhm, Fanny C Ip, et al.Pageof 252